Keyphrases
Monocytes
100%
Viral
100%
Central Nervous System
100%
Potential Therapy
100%
Viral Reservoir
100%
AIDS/HIV
88%
Combined Antiretroviral Therapy (cART)
55%
Human Immunodeficiency Virus Type 1 (HIV-1)
44%
CD141
44%
CD161
44%
People Living with HIV (PLHIV)
33%
Blood-brain Barrier
22%
Peripheral Blood Mononuclear Cells
22%
Transmigration
22%
Replenishment
22%
JAM-A
22%
ALCAM
22%
Selective Entry
22%
T Cells
11%
Virus
11%
Viral Replication
11%
Viral Proteins
11%
Chemokine (C-C motif) Ligand 2 (CCL2)
11%
CCR2
11%
Primary Infection
11%
Viral mRNA
11%
Therapeutic Target
11%
Culture in Vitro
11%
Virus Diseases
11%
Virus Reservoir
11%
Transcriptionally Active
11%
Associated Comorbidities
11%
Cenicriviroc
11%
Blood-brain Barrier Model
11%
People Living with Human Immunodeficiency Virus
11%
RNAscope
11%
Reservoir Formation
11%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Central Nervous System
100%
Viral Reservoir
100%
Human Immunodeficiency Virus 1
33%
Blood Brain Barrier
16%
ALCAM
16%
Peripheral Blood Mononuclear Cell
16%
T Cell
8%
Viral Protein
8%
Viral Replication
8%
CCL2
8%
CCR2
8%
Comorbidity
8%
Virus
8%
Infection
8%
In Vitro
8%
Agricultural and Biological Sciences
Human Immunodeficiency Virus
100%
Central Nervous System
100%
Human Immunodeficiency Virus 1
33%
Peripheral Blood Mononuclear Cell
16%
Activated Leukocyte Cell Adhesion Molecule
16%
Blood-Brain Barrier
16%
T Cell
8%
Virus Replication
8%
Viral Protein
8%
CCL2
8%
CCR2
8%
Messenger RNA
8%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Peripheral Blood Mononuclear Cell
16%
Blood Brain Barrier
16%
Activated Leukocyte Cell Adhesion Molecule
16%
Virus Replication
8%
Viral Protein
8%
CCR2
8%
T Cell
8%
CCL2
8%
Comorbidity
8%
Messenger RNA
8%